Finance

Lists
CSCI:TSE
COSCIENS Biopharma Inc
8,40 CAD
-1,18%
(-0,10) 1D
5-ноя., 16:00:00 GMT-5  ·   CAD
All symbols
SymbolPriceChange% Change
Generating top insights for CSCI...
Open
8,40 CAD
High
8,40 CAD
Low
8,40 CAD
Mkt. cap
8,92 млн
Avg. vol.
507,00
Volume
300,00
P/E ratio
0,95
52-wk high
14,80 CAD
52-wk low
3,30 CAD
EPS
8,81 CAD
Beta
1,73
Shares outstanding
996,39 миң
No. of employees
28
Open
8,40 CAD
High
8,40 CAD
Low
8,40 CAD
Mkt. cap
8,92 млн
Avg. vol.
507,00
Volume
300,00
P/E ratio
0,95
52-wk high
14,80 CAD
52-wk low
3,30 CAD
EPS
8,81 CAD
Beta
1,73
Shares outstanding
996,39 миң
No. of employees
28
News stories
From web sources and news partners
About COSCIENS Biopharma Inc
CEO-
Employees28
Founded1990
HeadquartersТоронто, Онтарио, Канада
SectorHealth Care
Industry-
Last report
2026-ж., 11-авг.
Fiscal period
Q2 2026
- / -
Revenue / Est. (USD)
3,14 млн / -
Fiscal Q2 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
2025-ж. сен.
2025-ж. дек.
2026-ж. мар.
2026-ж. июн.
Revenue
1,48 млн
1,77 млн
1,89 млн
3,14 млн
Cost of goods sold
938,00 миң
1,16 млн
1,10 млн
1,41 млн
Cost of revenue
938,00 миң
1,16 млн
1,10 млн
1,41 млн
Research and development expenses
527,00 миң
599,00 миң
176,00 миң
132,00 миң
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
2,10 млн
2,40 млн
1,35 млн
1,18 млн
Operating expense
2,63 млн
3,00 млн
1,52 млн
1,32 млн
Total operating expenses
3,57 млн
4,15 млн
2,62 млн
2,72 млн
Operating income
-2,08 млн
-2,39 млн
-730,00 миң
422,00 миң
Other non operating income
522,00 миң
240,00 миң
562,00 миң
-680,00 миң
EBT including unusual items
-1,82 млн
-2,17 млн
-183,00 миң
-202,00 миң
EBT excluding unusual items
-1,58 млн
-2,17 млн
-183,00 миң
-202,00 миң
Income tax expense
-
10,00 миң
-
-
Effective tax rate
-
-0,46%
-
-
Other operating expenses
-
-
-
-
Net income
-1,82 млн
-2,18 млн
10,76 млн
-202,00 миң
Net profit margin
-122,66%
-123,61%
569,76%
-6,43%
Earnings per share
-
-
-
-
Interest and investment income
57,00 миң
37,00 миң
20,00 миң
22,00 миң
Interest expense
-43,00 миң
-32,00 миң
-46,00 миң
-51,00 миң
Net interest expenses
14,00 миң
5,00 миң
-26,00 миң
-29,00 миң
Depreciation and amortization charges
-
-
-
-
EBITDA
-1,80 млн
-2,36 млн
-389,00 миң
759,00 миң
Gain or loss from assets sale
-
-
-11,28 млн
29,00 миң
Upcoming events
AI content may include mistakes. Learn more
Google колдонмолору